Supplementary Files
Keywords
Polycystic ovary syndrome
Hirsutism
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To provide knowledge about Polycystic Ovary Syndrome (PCOS), as well as the pathophysiology, etiology and conceivable therapeutic treatments. Bibliographic review: PCOS is a condition marked by hormonal imbalance in women. It is an endocrine anomaly that affects women of reproductive age, characterized by being spread in a highly hereditary way, in which such alteration is observed even in the uterine environment. Determined by irregular menstrual cycles, high levels of androgens in the body, small cysts on the ovaries, total absence of ovulation and/or irregular egg release from the ovaries, androgen excess, and clinical symptoms such as hirsutism, alopecia, acne, dysfunction, infertility, problems with body weight, in addition to being considered a risk factor for the development of other diseases. The therapeutic approach aims to condense the signs of hyperandrogenism, a dietary reeducation, and regularize the lipid profile of each patient. Final considerations: Therefore, this hormonal dysregulation can affect issues related to women's self-esteem and even make pregnancy difficult. Therefore, the relevance of an intervention by a multiprofessional team is observed, reducing the effects arising from the syndrome.
References
BEDNARSKA S, SIEJKA A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new?. Adv Clin Exp Med, 2017; 26(2): 359–367.
CAMPOS AE, et al. O impacto da mudança do estilo de vida em mulheres com síndrome dos ovários policísticos. Revista eletrônica Acervo Saúde, 2021; 13(2).
ESCOBAR-MORREALE HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 2018,14(5): 270-284.
GIORDANO MV, et al. Dispositivo intrauterino de cobre, Femina, 2015; 43(suppl.1): 15-20.
GOMES PCA. Aspectos ultrassonográficos na síndrome dos ovários policísticos: novas recomendações. Brazilian Journal of Health Review, 2021; 4(2): 6525-6535
HOEGER KM, et al. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J. Clin. Endocrinol. Metab, 2021; 106 (3): 1071-1083.
JIN P, YONGYONG X. Treatment strategies for women with polycystic ovary syndrome, Gynecol Endocrinol, 2018; 34 (4): 272-277.
LOPEZ JA, et al. Revisión de los criterios diagnósticos para el síndrome de ovario poliquístico. Medicas UIS, 2020; 3(3): 21-28.
MACEDO DB, et al. Avanços na etiologia, no diagnóstico e no tratamento da puberdade precoce central. Arq Bras Endocrinol Metab, 2018; 58 (2): 108-117.
MELO AS, et al. Mulheres com síndrome dos ovários policísticos apresentam maior frequência de síndrome metabólica independentemente do índice de massa corpórea. Rev. Bras. Ginecol. Obstet, 2012; 34 (1).
MINISTÉRIO DA SAÚDE. Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Comissão Nacional de Incorporação de Tecnologias no SUS. Protocolo Clínico e Diretrizes Terapêuticas para Síndrome dos Ovários Policísticos. Brasília – DF: Brasil, 2019. Disponível em: http://conitec.gov.br/images/Consultas/2019/Relatorio_PCDT_SindromeOvariosPolicisticos_CP05_2019.pdf. Acessado em: 22/02/2022.
MORAES, LAM, et al. Projeto Diretriz – Síndrome dos Ovários Policísticos. Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2002.
MOURA HHG, et al. Síndrome do ovário policístico: abordagem terapêutica dermatológica. Anais Brasileiro de dermatologia, 2011; 86 (1).
ROCHA AL, et al. Recent advances in the understanding and management of polycystic ovary syndrome, 2019; 565 (6).
ROSA-E-SILVA AC. Conceito, epidemiologia e fisiopatologia aplicada à prática clínica. In: Síndrome dos ovários policísticos, 2018; 1: 1-15.
SANCHEZ-GARRIDO MA, TENA-SEMPERE M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Molecular Metabolism, 2020, 35.
SANTANA LF, et al. Tratamento da infertilidade em mulheres com síndrome dos ovários policísticos. Revista Brasileira de Ginecologia e Obstetrícia, 2008; 30 (4).
SIR-PETERMANN T, et al Sindrome de ovario poliquístico diagnostico y manejo. Rev.med. clin. condes, 2013, 24(5):818-826.
SPRITZER PM. Polycystic Ovary Syndrome: Reviewing diagnosis and management of metabólica disturbances. Arq Bras Endocrinol Metab, 2014; 58(2).
VILLACIS SC, et al. Diagnostic criteria and therapeutic integral treatment of polycystic ovary syndrome. Rev Cubana Obstet Ginecol, 2017, 43(3): 173-181.
ZHANG J, et al. Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol, 2019, 17(1):67.